Side Effects and Longevity of Monopolar Transurethral Resection of the Prostate (M-TURP)
Monopolar TURP (M-TURP) delivers durable outcomes for up to 22 years but carries significant perioperative mortality (0.1%) and morbidity (11.1%) risks, making it effective but not without important complications. 1
Efficacy and Longevity
M-TURP remains the gold standard surgical procedure for men with prostate sizes between 30-80ml and bothersome moderate-to-severe lower urinary tract symptoms (LUTS) secondary to benign prostatic obstruction (BPO). Key points about its longevity:
- Delivers durable outcomes for up to 22 years 1
- Provides significant improvements in urinary flow rates, symptom scores, and post-void residual volumes 2
- Reoperation rates are approximately 7.2% compared to 18.4% for TUIP 1
- Provides the highest decrease in prostate volume (48.8%), best increase in maximum flow rate (75.3%), and highest decrease in residual volume (89.8%) compared to other minimally invasive treatments 2
Side Effects and Complications
Perioperative Complications (Short-term)
- Mortality rate: 0.1% 1
- Overall morbidity rate: 11.1% 1
- Prostate capsule perforation: 5.2% 3
- Severe bleeding requiring transfusion: 1.7% 3
- Urethral injury during the procedure 3
- TURP syndrome (dilutional hyponatremia): unique complication when irrigant solution is absorbed into bloodstream 1
- Longer catheterization and hospitalization times with preoperative use of oral anticoagulants or antiplatelet medications 1
Post-operative Complications (Medium to Long-term)
- Urinary tract infections: 7.8% 3
- Bulbar urethral stricture: 5.2% 3
- Bladder neck contracture: 1.7% 3
- Need for repeat TURP: 4% 3
- Sexual dysfunction (including retrograde ejaculation): 68% in sexually active men 4
- Irritative voiding symptoms 1
- Urinary incontinence: approximately 1% 1
According to the Clavien-Dindo complication grading system, the overall complication rate is approximately 29.3%, with about 96% of complications being grade I, II, or III, which can be managed conservatively or with minimally invasive surgery 3.
Comparison with Other Techniques
Bipolar TURP (B-TURP)
- Achieves comparable short, mid, and long-term results to M-TURP 1
- Has a more favorable perioperative safety profile than M-TURP 1
- Similar effects on overall sexual function (IIEF-15) and erectile function (IIEF-5) at 12 months 1
Transurethral Incision of the Prostate (TUIP)
- Appropriate for smaller prostates (<30ml) 1
- Similar efficacy and safety to M-TURP for treating moderate-to-severe LUTS 1
- Significantly lower retrograde ejaculation rate (35% vs 68%) 4
- Higher reoperation rate (18.4% vs 7.2%) 1
Clinical Decision-Making Algorithm
Prostate Size Assessment:
- <30ml: Consider TUIP (lower retrograde ejaculation risk but higher reoperation rate)
- 30-80ml: M-TURP or B-TURP (standard approach)
80ml: Consider open prostatectomy or laser enucleation techniques
Patient Risk Factors:
- Patients on anticoagulants/antiplatelets: Consider B-TURP or laser techniques over M-TURP
- High cardiovascular risk: B-TURP preferred over M-TURP due to better safety profile
Sexual Function Considerations:
- If preserving ejaculatory function is important: Consider TUIP for smaller prostates
- If erectile function is a major concern: No significant difference between M-TURP and B-TURP at 12 months
Important Caveats and Pitfalls
- Despite newer technologies, M-TURP remains the benchmark for surgical therapies due to published evidence of efficacy from randomized clinical trials with long-term follow-up 1
- The perioperative mortality and morbidity of M-TURP have decreased over time but remain significant 1
- Patients should be informed about the high rate of retrograde ejaculation (68%) which may affect sexual satisfaction 4
- TURP syndrome, though rare with modern irrigation techniques, remains a unique and potentially serious complication of M-TURP 1
- Preoperative use of anticoagulants requires careful management to reduce bleeding risks 1
In summary, while M-TURP provides excellent long-term outcomes for up to 22 years, patients must be counseled about the significant complication rate of approximately 29.3%, with most complications being manageable with conservative or minimally invasive approaches.